Copeland Capital Management’s Rentokil RTO Stock Holding History

Copeland Capital Management’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-106	Closed	-$3.12K	–	275
2025 Q4	$3.12K	Hold	106	–	–	﹤0.01%	271
2025 Q3	$2.68K	Hold	106	–	–	﹤0.01%	275
2025 Q2	$2.54K	Hold	106	–	–	﹤0.01%	269
2025 Q1	$2.43K	Hold	106	–	–	﹤0.01%	270
2024 Q4	$2.68K	Hold	106	–	–	﹤0.01%	275
2024 Q3	$2.64K	Buy	+106	New	+$3.14K	﹤0.01%	266
2024 Q2	–	Sell	-106	Closed	-$3.2K	–	227
2024 Q1	$3.2K	Buy	106 +24	+29%	+$666	﹤0.01%	245
2023 Q4	$2.35K	Hold	82	–	–	﹤0.01%	264
2023 Q3	$3.04K	Hold	82	–	–	﹤0.01%	247
2023 Q2	$3.2K	Hold	82	–	–	﹤0.01%	265
2023 Q1	$3K	Hold	82	–	–	﹤0.01%	244
2022 Q4	$3K	Buy	+82	New	+$2.54K	﹤0.01%	248

Other funds holding RTO

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GCM

Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Summitry LLC Foster City, California $3.04B AUM 17.05% 1-Year Est. Return

Copeland Capital Management's RTO Position: Q1 2026 in Review

Copeland Capital Management sold out of Rentokil (RTO) in Q1 2026, closing a stake of 106 shares — an estimated $3.12K sold.

Copeland Capital Management first reported a position in RTO in Q4 2022 and held it in 12 quarters. The position peaked at $3.2K in Q2 2023. 284 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

Copeland Capital Management reported no remaining Rentokil position as of Q1 2026 after selling out during the quarter.
Copeland Capital Management sold 106 Rentokil shares in Q1 2026, an estimated $3.12K.
Copeland Capital Management first reported a position in Rentokil in Q4 2022 and held it in 12 quarters.
Copeland Capital Management's Rentokil position peaked at $3.2K in Q2 2023.
284 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Copeland Capital Management's 13F filing for Q1 2026, filed 6 May 2026.